ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

European shares rise as Inditex leads retailers, Novo Nordisk shines
European shares experienced a rise, propelled by strong performances in the retail sector, particularly Inditex, which reported accelerated sales. Novo Nordisk also saw gains following its restructuring announcement, including workforce reductions, aimed a
Announcement as on 10 September 2025

European stocks rise as Novo Nordisk lifts healthcare on Wegovy data
Shares of Novo Nordisk, the fourth-largest healthcare company on the STOXX index, climbed 3.1% after the company said Wegovy cut the risk of heart attack, stroke or death by 57% versus Eli Lilly's rival medicines Mounjaro and Zepbound in a real-world compa
Announcement as on 01 September 2025

Novo Nordisk ties up with Apollo Clinics for obesity management initiative
Novo Nordisk partners with Apollo Clinics to tackle obesity in India. The collaboration introduces a comprehensive obesity management programme across Indian cities. This initiative aims to provide structured care through multiple levels. The partnership f
Announcement as on 01 September 2025

Natco Pharma sues Novo Nordisk in generic drug push
The lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its non-infringing patents but received no response, said people familiar with the matter. "A clear communication from t
Announcement as on 21 August 2025

Drugmaker Novo Nordisk freezes hiring for non-critical jobs
Novo Nordisk, the maker of Wegovy, has initiated a global hiring freeze for non-critical roles amid increasing competition and pressure from Eli Lilly. This decision follows a profit warning that led to a significant drop in market value and the appointmen
Announcement as on 20 August 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 48.11
  • 12Day Average: 48.45
  • 20Day Average: 48.15
  • 50Day Average: 49.83
  • 100Day Average: 52.38
  • 150Day Average: 58.32
  • 200Day Average: 61.02

NVO Indicators & signals

Indicator MACD (12,26,9)

48.38, 48.7, -0.43
Indicator MACD is in negative zone

Indicator ADX (14)

20, 19.75, 29.63
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Mon Dec 2025 48.11 47.59 to 48.84 0% 0.63 times
19 Fri Dec 2025 48.11 46.84 to 48.80 1.03% 0.7 times
18 Thu Dec 2025 47.62 47.52 to 48.31 -0.31% 0.54 times
17 Wed Dec 2025 47.77 47.73 to 48.75 -2.43% 0.67 times
16 Tue Dec 2025 48.96 48.41 to 49.97 -2.8% 1.2 times
15 Mon Dec 2025 50.37 49.55 to 50.66 0.38% 0.96 times
12 Fri Dec 2025 50.18 49.92 to 50.75 -0.22% 1.05 times
11 Thu Dec 2025 50.29 49.59 to 50.54 2.53% 1.32 times
10 Wed Dec 2025 49.05 47.04 to 49.50 5.8% 1.44 times
09 Tue Dec 2025 46.36 46.08 to 46.79 -0.88% 0.87 times
08 Mon Dec 2025 46.77 46.35 to 47.17 -2.26% 1.25 times
05 Fri Dec 2025 47.85 47.83 to 49.15 -0.29% 0.76 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top